E-resources
PDF-
Stehli, Julia, MD; Fuchs, Tobias A., MD; Ghadri, Jelena R., MD; Gaemperli, Oliver, MD; Fiechter, Michael, MD, PhD; Kaufmann, Philipp A., MD
Journal of the American College of Cardiology, 07/2014, Volume: 64, Issue: 1Journal Article
Smoking, leukemia or lymphoma, radio- or chemotherapy, and radiation-based examinations within the past 3 days were exclusion criteria. Because concerns about increased DSBs also have been raised for exposure to nonionizing radiation, such as that produced by cardiac magnetic resonance or ultrasound imaging (3,4), we only included controls who did not undergo any such examination to avoid potential confounders. ...a firm conclusion regarding the reduction of carcinogenic risk by antioxidant pre-treatment may not be offered, and further evaluation in larger trials should be encouraged.
